TY  - GEN
AU  - Yang,Hung-Chih
AU  - Tsou,Hsiao-Hui
AU  - Pei,Sung-Nan
AU  - Chang,Cheng-Shyong
AU  - Chen,Jia-Hong
AU  - Yao,Ming
AU  - Lin,Shyh-Jer
AU  - Lin,Johnson
AU  - Yuan,Quan
AU  - Xia,Ningshao
AU  - Liu,Tsang-Wu
AU  - Chen,Pei-Jer
AU  - Cheng,Ann-Lii
AU  - Hsu,Chiun
TI  - Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
SN  - 1600-0641
PY  - 2019///0920
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Antiviral Agents
KW  - Biomarkers
KW  - blood
KW  - DNA, Viral
KW  - Female
KW  - Hepatitis B
KW  - complications
KW  - Hepatitis B Antibodies
KW  - Hepatitis B Surface Antigens
KW  - Hepatitis B virus
KW  - physiology
KW  - Humans
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - Predictive Value of Tests
KW  - Risk Assessment
KW  - methods
KW  - Rituximab
KW  - Taiwan
KW  - Virus Activation
KW  - immunology
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jhep.2018.02.033
ER  -